Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that has a significant impact on quality of life and work capacity. It remains difficult to treat effectively, so this thesis develops a bioinformatics pipeline to repurpose existing drugs and identify synergistic combinations. By analysing high‑quality transcriptomic datasets from public repositories, the work links RA‑related gene expression patterns to compounds predicted to reverse harmful molecular signatures. Overall, the findings demonstrate that the proposed framework is an effective tool for accelerating drug discovery and suggest promising therapeutic avenues that warrant further experimental and clinical investigation.Thesis is embargoed until 31st July 2027.
| Date of Award | Jul 2025 |
|---|---|
| Original language | English |
| Sponsors | Department for the Economy |
| Supervisor | Shu-Dong Zhang (Supervisor), Tony Bjourson (Supervisor) & David Gibson (Supervisor) |
Keywords
- drug repurposing
Cite this
- Standard